Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,064 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Active, not recruiting

Hyperpolarized Imaging for New Treatments

NCT04259970

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • University of Virginia School of Medicine Charlottesville, Virginia, United States
  • University of Wisconsin Madison, Wisconsin, United States
  • The Hospital for Sick Kids Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Pulmonary Vascular Disease in CF

NCT04549077

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

NCT05444257

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner University of Arizona Medical Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Miller Children's Hospital / Long Beach Memorial Long Beach, California, United States
View all 195 locations
View Trial Details
Active, not recruiting

Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

NCT05331183

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Medizinische Universität Innsbruck - Heilstättenschule Universitätsklinik Innsbruck, Austria
  • CUB Hôpital Erasme Brussels, Belgium
  • UZ Brussel - Campus Jette Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen (UZA) - Antwerp University Hospital Edegem, Belgium
View all 81 locations
View Trial Details
Active, not recruiting

Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)

NCT04602468

Conditions
Adherence, Medication, Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • Children's Health Ireland at Crumlin Dublin, Leinster, Ireland
  • Children's Health Ireland at Temple Street Dublin, Ireland
  • St. Vincent's University Hospital Dublin, Ireland
  • Children's Health Ireland at Tallaght Tallaght, Ireland
View Trial Details
Active, not recruiting

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

NCT05668741

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham - Child Health Research Unit Birmingham, Alabama, United States
  • Memorial Health Services on behalf of Long Beach Memorial Medical Center d/b/a Miller Children's Hospital Long Beach Long Beach, California, United States
  • Stanford University - Palo Alto - Pulmonology Palo Alto, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 26 locations
View Trial Details
Active, not recruiting

COVID-19 Antibody Responses In Cystic Fibrosis

NCT04863573

Conditions
COVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, +16 more
Locations
  • University Hospital Southampton Nhs Foundation Trust Southampton, Engladn, United Kingdom
  • University Hospitals Birmingham Nhs Foundation Trust Birmingham, England, United Kingdom
  • Birmingham Women'S and Children'S Nhs Foundation Trust Birmingham, England, United Kingdom
  • Leeds Teaching Hospitals Nhs Trust Leeds, England, United Kingdom
View Trial Details
Active, not recruiting

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

NCT06237335

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • UCSD San Diego, California, United States
View all 23 locations
View Trial Details

Related conditions